Newsroom

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Hercules Capital, Inc. (“Hercules Capital” or the “Company”) (NYSE: HTGC) securities between May 1, 2025 and February 27, 2026, inclusive (the “Class Period”). Hercules Capital investors have until May 19, 2026 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN HERCULES CAPITAL, INC. (HTGC), CONTACT THE LAW OFFICES O...

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Hitek Global Inc. (NASDAQ: HKIT) resulting from allegations that Hitek Global Inc. may have issued materially misleading business information to the investing public. So what: If you purchased Hitek securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrang...

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Power Solutions International, Inc. (NASDAQ: PSIX) securities between May 8, 2025 and March 2, 2026. Power Solutions designs, manufactures, and sells engines and power systems. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations tha...

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) resulting from allegations that Aldeyra may have issued materially misleading business information to the investing public. So What: If you purchased Aldeyra securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arran...

LOS ANGELES--(BUSINESS WIRE)--IMMP Investors Have Opportunity to Join Immutep Limited Fraud Investigation with the Schall Law Firm...

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of SYLA Technologies Co., Ltd. (NASDAQ: SYT) resulting from allegations that SYLA Technologies Co., Ltd. may have issued materially misleading business information to the investing public. So what: If you purchased SYLA Technologies securities you may be entitled to compensation without payment of any out of pocket fees or costs t...

LOS ANGELES--(BUSINESS WIRE)--TBRG Investors Have Opportunity to Join TruBridge, Inc. Fraud Investigation with the Schall Law Firm...

LOS ANGELES--(BUSINESS WIRE)--VRCA Investors Have the Opportunity to Join Investigation of Verrica Pharmaceuticals Inc. with the Schall Law Firm...

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) oggi ha annunciato che i dati provenienti da programmi importanti nella sua serie franchise Inflammation and Autoimmunity (IAI) verranno presentati al Meeting annuale 2026 della American Academy of Dermatology (AAD), che si svolgerà a Denver dal 27 al 31 marzo 2026. “All'AAD 2026, presenteremo gli ultimi risultati ottenuti in 54 settimane dal programma di Fase 3 STOP‑HS di valutazione del povorcitinib nell'idrosadenite suppurativa (HS)”, h...

WILMINGTON, Delaware--(BUSINESS WIRE)--Incyte (Nasdaq : INCY) a annoncé aujourd’hui que les données issues des programmes clés de sa division Inflammation et Auto-immunité (IAI) seront présentées lors du congrès annuel 2026 de l’Académie américaine de dermatologie (AAD), qui se tiendra du 27 au 31 mars 2026 à Denver. « Lors de l’AAD 2026, nous présenterons les derniers résultats à 54 semaines du programme de phase 3 STOP-HS évaluant le povorcitinib dans l’hidradénite suppurée (HS) », déclare Ji...